Colgate-Palmolive (India) Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/j37xpdywgoj0rjwsn1sxup46.pdf

Key Takeaways


Demand Environment & Category Health

Prabha Narasimhan: "it is our accountability, it's our responsibility, and actually it's our privilege to lead the growth of the Toothpaste category and to drive consumption"

Product Superiority & Brand Reinvestment

Prabha Narasimhan: "This has been by far Colgate's most successful innovation in the history of Colgate."

Execution & Distribution

Prabha Narasimhan: "A real win-win partnership between us and the dentist and the consumer because the consumer gets better oral health, the dentist gets more patients, and for us better oral health is absolutely a win."

Margins & Cost Structure

M.S. Jacob: "We are not looking to specifically drive a percentage EBITDA here. Top-line growth driven by volume and moving the absolute level of profit would be the key priority."

Innovation Pipeline & New Launches


AI, Technology & Sustainability

Prabha Narasimhan: "I think everybody is learning. It's an exciting space. We are doing a lot of effort to make sure that we are building capability. Of course, everybody realizes that if you are not using it and you are not figuring out AI, then you are going to be a fossil or a dinosaur very soon."

Guidance & Commitments

CommitmentSpecificsTimeline
PricingLow-single-digit pricing to be put through, depending on cost increases by categoryNext few weeks
Gross marginContinue in the current rangeNext two quarters
EBITDA marginStep up from Q4's seasonally low 12.6% levelComing quarters
Advertising investmentContinue to step up to drive growth, calibrated to elasticityOngoing
B2B dentist field forceAugment the current ~150 feet on streetNot specified
Rural consumptionUse Uttar Pradesh pilot learnings as a pillar to drive rural consumptionThrough this year
Colgate Strong Teeth clinical claimTake the 8.5x re-mineralization data forward in the market"Very, very soon"
Harry Potter rangeLaunch the co-branded range"Very, very soon"
Palmolive Body WashSignificantly more digital-first approach via a partnershipThis year
Therapeutics playDouble down on the B2B channel as the therapeutics play becomes biggerNot specified
Premium strategyDouble down; premium remains a critical pillarOngoing
Volume growthDeliver balanced volume and pricing growth, not relying on pricing as much as in the pastGoing forward
Dividend payoutVirtually 100% of NPAT paid out as dividendCurrent policy

Key Metrics

MetricQ4 FY26
Net sales₹1,583 crores, 9% YoY growth
Domestic growth9.2%
Gross margin69.6%
EBITDA margin32.2%, includes 160 bps impact from GST inverted duty structure
Brand investments12.6% of sales, up 10% in absolute terms YoY
Net profit after tax₹353 crores
Net profit growth (excl. one-offs)9% YoY
Full-year net sales₹5,984 crores, flat YoY
Full-year EBITDA margin31.2%, includes 80 bps impact from GST inverted duty structure
Full-year brand investments13.7% of sales
Premiumization mix increase35% over the past two years
E-commerce and quick commerce channel share~10% of business
Return on capital employed121%
Cash generated₹1,806 crores (full year)
Dividend per share~₹48 (full year), ~100% of NPAT payout